23andMe Holding Co. reported earnings results for the fourth quarter and full year ended March 31, 2024. For the fourth quarter, the company reported revenue was USD 64.03 million compared to USD.
23andMe Holding Co (NASDAQ:ME) Q4 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.
23andMe Gains as Revenue Beats Despite Flagging DNA Sales
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
Petros Pharmaceuticals Launches U S Distribution of Prescription ED
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.
Petros Pharmaceuticals, Inc : Petros Pharmaceuticals Launches U S Distribution of Prescription ED Medication STENDRA Through Recently Announced Collaboration With Lemonaid Health, a Subsidiary of 23andMe
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.